Site Editors

Alexander Drilon, MD

Gregory J. Riely, MD, PhD

Advertisement
Advertisement

Published Medical Literature

NTRK1-TPM3 Gene Rearrangement in Recurrent Ovarian Cancer: Case Report
How Common Are NTRK Fusions in Bone Tumors in Pediatric Patients?
Rare Case of Mesenchymal Sarcoma With NTRK1 Gene Translocation
European Pediatric Sequencing Programs: Screening for Targetable NTRK Gene Fusions
Differentiated Thyroid Cancer: Molecular Profiling for NTRK Gene Fusions in Assessing Risk for Recurrence
NTRK3 Promoter Methylation: Predictive Marker for Survival in Colorectal Cancer?
Rare Case of Mosaicism in a Glioblastoma Harboring NTRK Fusion and PDGFRA Amplification
Larotrectinib for Pediatric Undifferentiated Sarcoma With an STRN-NTRK2 Fusion: Case Study
Larotrectinib in RAI-Refractory Papillary Thyroid Cancer: Case Report
NTRK Fusion–Positive Solid Tumors: Entrectinib Granted Conditional Marketing Authorization in the European Union
Can Pan-TRK Immunohistochemistry Identify NTRK Fusions in Lung Cancer?
Case Report: Use of Larotrectinib in a Boy With TRK Fusion–Positive ALL
NTRK Fusions and Cancer: Focus on Biology and Therapeutic Targeting of These Drivers
Shedding Light on the Landscape of NTRK Aberrations in Pediatric and Adult Tumors
Novel TFG‐NTRK2 Fusion in Spitz/Reed Tumor: Case Report
Entrectinib in NTRK Fusion– and ROS1 Fusion–Positive Solid Tumors: Patient-Reported Outcomes
Identifying NTRK Gene Fusions for Targeted Therapy: ‘An Ongoing Clinical Priority’
Larotrectinib for Advanced Lung Cancer With Novel NCOR2-NTRK1 Fusion: Case Study
Study Identifies Benefits of Testing for NTRK Fusions in Thyroid Cancers
Understanding NTRK Fusion Actionability: An Overview of Targeted Therapy Options
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.